INTERNATIONAL IMMUNOPHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152406, encodeId=355d2152406b2, content=偏重的研究方向：免疫;炎症;炎症反应 经验分享：8-3投稿，8-8 wi th editor，8-9 under review，大家多久找到审稿人的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=582a5379085, createdName=重重的八毛, createdTime=Sat Aug 12 10:51:40 CST 2023, time=2023-08-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1234356, encodeId=ff93123435630, content=偏重的研究方向：炎症;生信 经验分享：记录一下，5月7号投稿，5月24显示under review，从审核到现在两个月了，目前有一个专家完成评论，不知道有几个外审专家，希望有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0c6429640, createdName=ms4000000081520044, createdTime=Sun Jul 24 09:44:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927299, encodeId=488892e29963, content=两天就变成under review，一直在这个状态一个半月了，之前一个月还每周更新一次状态下日期。现在都还没有消息。大家一审花了多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=I63lR39aCnJzDFhywY4s2w&s=100&t=1556924152, createdBy=09d55352037, createdName=ms8848229887753939, createdTime=Fri Feb 26 09:22:37 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238192, encodeId=b52a123819246, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：免疫;药理学 经验分享：2022.6.18 提交 2022.6.21外审 2022.7.11大修 2022.7.31修回 2022.8.8接受 😭很不容易的文章，终于在这里接受了，感觉编辑很好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Fri Aug 12 02:29:45 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888191, encodeId=ea17888191c5, content=投稿命中率:25.0 经验分享：以前烂文水文都往这水刊上面灌，现在做了bitch还想立牌坊。碰到无脑编辑放权给无脑学生不送审真没办法，中国人害中国人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=581e2447283, createdName=alks, createdTime=Fri Sep 25 10:28:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116035, encodeId=86e42116035a0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有人有一个半月都找不到审稿人的人么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e175120089, createdName=14633662m06(暂无昵称), createdTime=Thu Feb 23 08:52:03 CST 2023, time=2023-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098518, encodeId=df432098518a3, content=7月19号投稿，当天就送审了，但是到现在已经三个半月了，依然是Reviews completed: 1，发了催稿信也完全没有回复，想知道大家的提交的文章审稿周期都这么久吗？感觉再这样拖下去很难毕业啊，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d31d5419802, createdName=ms3000000019619113, createdTime=Fri Nov 04 16:54:19 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2023-03-21 ms9833658896231706 来自江苏省

2023-03-03投稿
03-06 with editor
03-09 under review
03-15 under review
后续有进展再来。

52 35

展开35条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152406, encodeId=355d2152406b2, content=偏重的研究方向：免疫;炎症;炎症反应 经验分享：8-3投稿，8-8 wi th editor，8-9 under review，大家多久找到审稿人的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=582a5379085, createdName=重重的八毛, createdTime=Sat Aug 12 10:51:40 CST 2023, time=2023-08-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1234356, encodeId=ff93123435630, content=偏重的研究方向：炎症;生信 经验分享：记录一下，5月7号投稿，5月24显示under review，从审核到现在两个月了，目前有一个专家完成评论，不知道有几个外审专家，希望有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0c6429640, createdName=ms4000000081520044, createdTime=Sun Jul 24 09:44:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927299, encodeId=488892e29963, content=两天就变成under review，一直在这个状态一个半月了，之前一个月还每周更新一次状态下日期。现在都还没有消息。大家一审花了多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=I63lR39aCnJzDFhywY4s2w&s=100&t=1556924152, createdBy=09d55352037, createdName=ms8848229887753939, createdTime=Fri Feb 26 09:22:37 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238192, encodeId=b52a123819246, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：免疫;药理学 经验分享：2022.6.18 提交 2022.6.21外审 2022.7.11大修 2022.7.31修回 2022.8.8接受 😭很不容易的文章，终于在这里接受了，感觉编辑很好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Fri Aug 12 02:29:45 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888191, encodeId=ea17888191c5, content=投稿命中率:25.0 经验分享：以前烂文水文都往这水刊上面灌，现在做了bitch还想立牌坊。碰到无脑编辑放权给无脑学生不送审真没办法，中国人害中国人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=581e2447283, createdName=alks, createdTime=Fri Sep 25 10:28:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116035, encodeId=86e42116035a0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有人有一个半月都找不到审稿人的人么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e175120089, createdName=14633662m06(暂无昵称), createdTime=Thu Feb 23 08:52:03 CST 2023, time=2023-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098518, encodeId=df432098518a3, content=7月19号投稿，当天就送审了，但是到现在已经三个半月了，依然是Reviews completed: 1，发了催稿信也完全没有回复，想知道大家的提交的文章审稿周期都这么久吗？感觉再这样拖下去很难毕业啊，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d31d5419802, createdName=ms3000000019619113, createdTime=Fri Nov 04 16:54:19 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2024-01-09 洛洛仔111 来自北京

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：免疫学;生信
经验分享：投了五天了还是submit状态，后续更新进度

79 33

展开33条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152406, encodeId=355d2152406b2, content=偏重的研究方向：免疫;炎症;炎症反应 经验分享：8-3投稿，8-8 wi th editor，8-9 under review，大家多久找到审稿人的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=582a5379085, createdName=重重的八毛, createdTime=Sat Aug 12 10:51:40 CST 2023, time=2023-08-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1234356, encodeId=ff93123435630, content=偏重的研究方向：炎症;生信 经验分享：记录一下，5月7号投稿，5月24显示under review，从审核到现在两个月了，目前有一个专家完成评论，不知道有几个外审专家，希望有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0c6429640, createdName=ms4000000081520044, createdTime=Sun Jul 24 09:44:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927299, encodeId=488892e29963, content=两天就变成under review，一直在这个状态一个半月了，之前一个月还每周更新一次状态下日期。现在都还没有消息。大家一审花了多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=I63lR39aCnJzDFhywY4s2w&s=100&t=1556924152, createdBy=09d55352037, createdName=ms8848229887753939, createdTime=Fri Feb 26 09:22:37 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238192, encodeId=b52a123819246, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：免疫;药理学 经验分享：2022.6.18 提交 2022.6.21外审 2022.7.11大修 2022.7.31修回 2022.8.8接受 😭很不容易的文章，终于在这里接受了，感觉编辑很好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Fri Aug 12 02:29:45 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888191, encodeId=ea17888191c5, content=投稿命中率:25.0 经验分享：以前烂文水文都往这水刊上面灌，现在做了bitch还想立牌坊。碰到无脑编辑放权给无脑学生不送审真没办法，中国人害中国人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=581e2447283, createdName=alks, createdTime=Fri Sep 25 10:28:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116035, encodeId=86e42116035a0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有人有一个半月都找不到审稿人的人么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e175120089, createdName=14633662m06(暂无昵称), createdTime=Thu Feb 23 08:52:03 CST 2023, time=2023-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098518, encodeId=df432098518a3, content=7月19号投稿，当天就送审了，但是到现在已经三个半月了，依然是Reviews completed: 1，发了催稿信也完全没有回复，想知道大家的提交的文章审稿周期都这么久吗？感觉再这样拖下去很难毕业啊，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d31d5419802, createdName=ms3000000019619113, createdTime=Fri Nov 04 16:54:19 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2023-08-12 重重的八毛来自辽宁省

偏重的研究方向：免疫;炎症;炎症反应
经验分享：8-3投稿，8-8 wi th editor，8-9 under review，大家多久找到审稿人的？

37 32

展开32条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152406, encodeId=355d2152406b2, content=偏重的研究方向：免疫;炎症;炎症反应 经验分享：8-3投稿，8-8 wi th editor，8-9 under review，大家多久找到审稿人的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=582a5379085, createdName=重重的八毛, createdTime=Sat Aug 12 10:51:40 CST 2023, time=2023-08-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1234356, encodeId=ff93123435630, content=偏重的研究方向：炎症;生信 经验分享：记录一下，5月7号投稿，5月24显示under review，从审核到现在两个月了，目前有一个专家完成评论，不知道有几个外审专家，希望有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0c6429640, createdName=ms4000000081520044, createdTime=Sun Jul 24 09:44:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927299, encodeId=488892e29963, content=两天就变成under review，一直在这个状态一个半月了，之前一个月还每周更新一次状态下日期。现在都还没有消息。大家一审花了多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=I63lR39aCnJzDFhywY4s2w&s=100&t=1556924152, createdBy=09d55352037, createdName=ms8848229887753939, createdTime=Fri Feb 26 09:22:37 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238192, encodeId=b52a123819246, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：免疫;药理学 经验分享：2022.6.18 提交 2022.6.21外审 2022.7.11大修 2022.7.31修回 2022.8.8接受 😭很不容易的文章，终于在这里接受了，感觉编辑很好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Fri Aug 12 02:29:45 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888191, encodeId=ea17888191c5, content=投稿命中率:25.0 经验分享：以前烂文水文都往这水刊上面灌，现在做了bitch还想立牌坊。碰到无脑编辑放权给无脑学生不送审真没办法，中国人害中国人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=581e2447283, createdName=alks, createdTime=Fri Sep 25 10:28:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116035, encodeId=86e42116035a0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有人有一个半月都找不到审稿人的人么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e175120089, createdName=14633662m06(暂无昵称), createdTime=Thu Feb 23 08:52:03 CST 2023, time=2023-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098518, encodeId=df432098518a3, content=7月19号投稿，当天就送审了，但是到现在已经三个半月了，依然是Reviews completed: 1，发了催稿信也完全没有回复，想知道大家的提交的文章审稿周期都这么久吗？感觉再这样拖下去很难毕业啊，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d31d5419802, createdName=ms3000000019619113, createdTime=Fri Nov 04 16:54:19 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2022-07-24 ms4000000081520044

偏重的研究方向：炎症;生信
经验分享：记录一下，5月7号投稿，5月24显示under review，从审核到现在两个月了，目前有一个专家完成评论，不知道有几个外审专家，希望有好消息。

54 23

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152406, encodeId=355d2152406b2, content=偏重的研究方向：免疫;炎症;炎症反应 经验分享：8-3投稿，8-8 wi th editor，8-9 under review，大家多久找到审稿人的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=582a5379085, createdName=重重的八毛, createdTime=Sat Aug 12 10:51:40 CST 2023, time=2023-08-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1234356, encodeId=ff93123435630, content=偏重的研究方向：炎症;生信 经验分享：记录一下，5月7号投稿，5月24显示under review，从审核到现在两个月了，目前有一个专家完成评论，不知道有几个外审专家，希望有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0c6429640, createdName=ms4000000081520044, createdTime=Sun Jul 24 09:44:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927299, encodeId=488892e29963, content=两天就变成under review，一直在这个状态一个半月了，之前一个月还每周更新一次状态下日期。现在都还没有消息。大家一审花了多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=I63lR39aCnJzDFhywY4s2w&s=100&t=1556924152, createdBy=09d55352037, createdName=ms8848229887753939, createdTime=Fri Feb 26 09:22:37 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238192, encodeId=b52a123819246, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：免疫;药理学 经验分享：2022.6.18 提交 2022.6.21外审 2022.7.11大修 2022.7.31修回 2022.8.8接受 😭很不容易的文章，终于在这里接受了，感觉编辑很好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Fri Aug 12 02:29:45 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888191, encodeId=ea17888191c5, content=投稿命中率:25.0 经验分享：以前烂文水文都往这水刊上面灌，现在做了bitch还想立牌坊。碰到无脑编辑放权给无脑学生不送审真没办法，中国人害中国人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=581e2447283, createdName=alks, createdTime=Fri Sep 25 10:28:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116035, encodeId=86e42116035a0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有人有一个半月都找不到审稿人的人么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e175120089, createdName=14633662m06(暂无昵称), createdTime=Thu Feb 23 08:52:03 CST 2023, time=2023-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098518, encodeId=df432098518a3, content=7月19号投稿，当天就送审了，但是到现在已经三个半月了，依然是Reviews completed: 1，发了催稿信也完全没有回复，想知道大家的提交的文章审稿周期都这么久吗？感觉再这样拖下去很难毕业啊，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d31d5419802, createdName=ms3000000019619113, createdTime=Fri Nov 04 16:54:19 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2021-02-26 ms8848229887753939

两天就变成under review，一直在这个状态一个半月了，之前一个月还每周更新一次状态下日期。现在都还没有消息。大家一审花了多长时间呢？

120 23

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152406, encodeId=355d2152406b2, content=偏重的研究方向：免疫;炎症;炎症反应 经验分享：8-3投稿，8-8 wi th editor，8-9 under review，大家多久找到审稿人的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=582a5379085, createdName=重重的八毛, createdTime=Sat Aug 12 10:51:40 CST 2023, time=2023-08-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1234356, encodeId=ff93123435630, content=偏重的研究方向：炎症;生信 经验分享：记录一下，5月7号投稿，5月24显示under review，从审核到现在两个月了，目前有一个专家完成评论，不知道有几个外审专家，希望有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0c6429640, createdName=ms4000000081520044, createdTime=Sun Jul 24 09:44:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927299, encodeId=488892e29963, content=两天就变成under review，一直在这个状态一个半月了，之前一个月还每周更新一次状态下日期。现在都还没有消息。大家一审花了多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=I63lR39aCnJzDFhywY4s2w&s=100&t=1556924152, createdBy=09d55352037, createdName=ms8848229887753939, createdTime=Fri Feb 26 09:22:37 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238192, encodeId=b52a123819246, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：免疫;药理学 经验分享：2022.6.18 提交 2022.6.21外审 2022.7.11大修 2022.7.31修回 2022.8.8接受 😭很不容易的文章，终于在这里接受了，感觉编辑很好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Fri Aug 12 02:29:45 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888191, encodeId=ea17888191c5, content=投稿命中率:25.0 经验分享：以前烂文水文都往这水刊上面灌，现在做了bitch还想立牌坊。碰到无脑编辑放权给无脑学生不送审真没办法，中国人害中国人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=581e2447283, createdName=alks, createdTime=Fri Sep 25 10:28:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116035, encodeId=86e42116035a0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有人有一个半月都找不到审稿人的人么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e175120089, createdName=14633662m06(暂无昵称), createdTime=Thu Feb 23 08:52:03 CST 2023, time=2023-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098518, encodeId=df432098518a3, content=7月19号投稿，当天就送审了，但是到现在已经三个半月了，依然是Reviews completed: 1，发了催稿信也完全没有回复，想知道大家的提交的文章审稿周期都这么久吗？感觉再这样拖下去很难毕业啊，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d31d5419802, createdName=ms3000000019619113, createdTime=Fri Nov 04 16:54:19 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2022-08-12 ms5000001105610949

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：免疫;药理学
经验分享：2022.6.18 提交 2022.6.21外审 2022.7.11大修 2022.7.31修回 2022.8.8接受 😭很不容易的文章，终于在这里接受了，感觉编辑很好！

80 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152406, encodeId=355d2152406b2, content=偏重的研究方向：免疫;炎症;炎症反应 经验分享：8-3投稿，8-8 wi th editor，8-9 under review，大家多久找到审稿人的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=582a5379085, createdName=重重的八毛, createdTime=Sat Aug 12 10:51:40 CST 2023, time=2023-08-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1234356, encodeId=ff93123435630, content=偏重的研究方向：炎症;生信 经验分享：记录一下，5月7号投稿，5月24显示under review，从审核到现在两个月了，目前有一个专家完成评论，不知道有几个外审专家，希望有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0c6429640, createdName=ms4000000081520044, createdTime=Sun Jul 24 09:44:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927299, encodeId=488892e29963, content=两天就变成under review，一直在这个状态一个半月了，之前一个月还每周更新一次状态下日期。现在都还没有消息。大家一审花了多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=I63lR39aCnJzDFhywY4s2w&s=100&t=1556924152, createdBy=09d55352037, createdName=ms8848229887753939, createdTime=Fri Feb 26 09:22:37 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238192, encodeId=b52a123819246, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：免疫;药理学 经验分享：2022.6.18 提交 2022.6.21外审 2022.7.11大修 2022.7.31修回 2022.8.8接受 😭很不容易的文章，终于在这里接受了，感觉编辑很好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Fri Aug 12 02:29:45 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888191, encodeId=ea17888191c5, content=投稿命中率:25.0 经验分享：以前烂文水文都往这水刊上面灌，现在做了bitch还想立牌坊。碰到无脑编辑放权给无脑学生不送审真没办法，中国人害中国人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=581e2447283, createdName=alks, createdTime=Fri Sep 25 10:28:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116035, encodeId=86e42116035a0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有人有一个半月都找不到审稿人的人么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e175120089, createdName=14633662m06(暂无昵称), createdTime=Thu Feb 23 08:52:03 CST 2023, time=2023-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098518, encodeId=df432098518a3, content=7月19号投稿，当天就送审了，但是到现在已经三个半月了，依然是Reviews completed: 1，发了催稿信也完全没有回复，想知道大家的提交的文章审稿周期都这么久吗？感觉再这样拖下去很难毕业啊，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d31d5419802, createdName=ms3000000019619113, createdTime=Fri Nov 04 16:54:19 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2020-09-25 alks

投稿命中率:25.0
经验分享：以前烂文水文都往这水刊上面灌，现在做了bitch还想立牌坊。碰到无脑编辑放权给无脑学生不送审真没办法，中国人害中国人。

226 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152406, encodeId=355d2152406b2, content=偏重的研究方向：免疫;炎症;炎症反应 经验分享：8-3投稿，8-8 wi th editor，8-9 under review，大家多久找到审稿人的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=582a5379085, createdName=重重的八毛, createdTime=Sat Aug 12 10:51:40 CST 2023, time=2023-08-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1234356, encodeId=ff93123435630, content=偏重的研究方向：炎症;生信 经验分享：记录一下，5月7号投稿，5月24显示under review，从审核到现在两个月了，目前有一个专家完成评论，不知道有几个外审专家，希望有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0c6429640, createdName=ms4000000081520044, createdTime=Sun Jul 24 09:44:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927299, encodeId=488892e29963, content=两天就变成under review，一直在这个状态一个半月了，之前一个月还每周更新一次状态下日期。现在都还没有消息。大家一审花了多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=I63lR39aCnJzDFhywY4s2w&s=100&t=1556924152, createdBy=09d55352037, createdName=ms8848229887753939, createdTime=Fri Feb 26 09:22:37 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238192, encodeId=b52a123819246, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：免疫;药理学 经验分享：2022.6.18 提交 2022.6.21外审 2022.7.11大修 2022.7.31修回 2022.8.8接受 😭很不容易的文章，终于在这里接受了，感觉编辑很好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Fri Aug 12 02:29:45 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888191, encodeId=ea17888191c5, content=投稿命中率:25.0 经验分享：以前烂文水文都往这水刊上面灌，现在做了bitch还想立牌坊。碰到无脑编辑放权给无脑学生不送审真没办法，中国人害中国人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=581e2447283, createdName=alks, createdTime=Fri Sep 25 10:28:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116035, encodeId=86e42116035a0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有人有一个半月都找不到审稿人的人么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e175120089, createdName=14633662m06(暂无昵称), createdTime=Thu Feb 23 08:52:03 CST 2023, time=2023-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098518, encodeId=df432098518a3, content=7月19号投稿，当天就送审了，但是到现在已经三个半月了，依然是Reviews completed: 1，发了催稿信也完全没有回复，想知道大家的提交的文章审稿周期都这么久吗？感觉再这样拖下去很难毕业啊，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d31d5419802, createdName=ms3000000019619113, createdTime=Fri Nov 04 16:54:19 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2023-02-23 14633662m06(暂无昵称) 来自湖北省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：有人有一个半月都找不到审稿人的人么？

33 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152406, encodeId=355d2152406b2, content=偏重的研究方向：免疫;炎症;炎症反应 经验分享：8-3投稿，8-8 wi th editor，8-9 under review，大家多久找到审稿人的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=582a5379085, createdName=重重的八毛, createdTime=Sat Aug 12 10:51:40 CST 2023, time=2023-08-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1234356, encodeId=ff93123435630, content=偏重的研究方向：炎症;生信 经验分享：记录一下，5月7号投稿，5月24显示under review，从审核到现在两个月了，目前有一个专家完成评论，不知道有几个外审专家，希望有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0c6429640, createdName=ms4000000081520044, createdTime=Sun Jul 24 09:44:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927299, encodeId=488892e29963, content=两天就变成under review，一直在这个状态一个半月了，之前一个月还每周更新一次状态下日期。现在都还没有消息。大家一审花了多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=I63lR39aCnJzDFhywY4s2w&s=100&t=1556924152, createdBy=09d55352037, createdName=ms8848229887753939, createdTime=Fri Feb 26 09:22:37 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238192, encodeId=b52a123819246, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：免疫;药理学 经验分享：2022.6.18 提交 2022.6.21外审 2022.7.11大修 2022.7.31修回 2022.8.8接受 😭很不容易的文章，终于在这里接受了，感觉编辑很好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Fri Aug 12 02:29:45 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888191, encodeId=ea17888191c5, content=投稿命中率:25.0 经验分享：以前烂文水文都往这水刊上面灌，现在做了bitch还想立牌坊。碰到无脑编辑放权给无脑学生不送审真没办法，中国人害中国人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=581e2447283, createdName=alks, createdTime=Fri Sep 25 10:28:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116035, encodeId=86e42116035a0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有人有一个半月都找不到审稿人的人么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e175120089, createdName=14633662m06(暂无昵称), createdTime=Thu Feb 23 08:52:03 CST 2023, time=2023-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098518, encodeId=df432098518a3, content=7月19号投稿，当天就送审了，但是到现在已经三个半月了，依然是Reviews completed: 1，发了催稿信也完全没有回复，想知道大家的提交的文章审稿周期都这么久吗？感觉再这样拖下去很难毕业啊，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d31d5419802, createdName=ms3000000019619113, createdTime=Fri Nov 04 16:54:19 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2021-09-06 ms2000002145400630

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩

87 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2120704, encodeId=32302120e0483, content=2023-03-03投稿 03-06 with editor 03-09 under review 03-15 under review 后续有进展再来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=35, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/7xB3OdNLiaPjMD3qablwtib0m6Cckoj1K7cJkOI6CTrDh9Epco1zYLOtzs7icSgITEtJucVKNxnNLF34qG5GyxoZQ/0, createdBy=e71e2167526, createdName=ms9833658896231706, createdTime=Tue Mar 21 08:40:11 CST 2023, time=2023-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2180287, encodeId=c88c218028e83, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：免疫学;生信 经验分享：投了五天了还是submit状态，后续更新进度, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Jan 09 17:26:21 CST 2024, time=2024-01-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2152406, encodeId=355d2152406b2, content=偏重的研究方向：免疫;炎症;炎症反应 经验分享：8-3投稿，8-8 wi th editor，8-9 under review，大家多久找到审稿人的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=582a5379085, createdName=重重的八毛, createdTime=Sat Aug 12 10:51:40 CST 2023, time=2023-08-12, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1234356, encodeId=ff93123435630, content=偏重的研究方向：炎症;生信 经验分享：记录一下，5月7号投稿，5月24显示under review，从审核到现在两个月了，目前有一个专家完成评论，不知道有几个外审专家，希望有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0c6429640, createdName=ms4000000081520044, createdTime=Sun Jul 24 09:44:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927299, encodeId=488892e29963, content=两天就变成under review，一直在这个状态一个半月了，之前一个月还每周更新一次状态下日期。现在都还没有消息。大家一审花了多长时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=I63lR39aCnJzDFhywY4s2w&s=100&t=1556924152, createdBy=09d55352037, createdName=ms8848229887753939, createdTime=Fri Feb 26 09:22:37 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238192, encodeId=b52a123819246, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：免疫;药理学 经验分享：2022.6.18 提交 2022.6.21外审 2022.7.11大修 2022.7.31修回 2022.8.8接受 😭很不容易的文章，终于在这里接受了，感觉编辑很好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Fri Aug 12 02:29:45 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888191, encodeId=ea17888191c5, content=投稿命中率:25.0 经验分享：以前烂文水文都往这水刊上面灌，现在做了bitch还想立牌坊。碰到无脑编辑放权给无脑学生不送审真没办法，中国人害中国人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=581e2447283, createdName=alks, createdTime=Fri Sep 25 10:28:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116035, encodeId=86e42116035a0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：有人有一个半月都找不到审稿人的人么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e175120089, createdName=14633662m06(暂无昵称), createdTime=Thu Feb 23 08:52:03 CST 2023, time=2023-02-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1015092, encodeId=e7c81015092a5, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：人生第一篇SCI，是一篇肿瘤相关的纯生信文章。7月2日投稿，中间焦急不安的等待。编辑很给力，一周多久under review。一审21天，7月底返回——大修。当时心凉凉的，其中一个审稿人问题比较难，要求补充实验。修了一个月，能补充的尽量补充，8月23日返修后，9月5日接受了。从投稿接收2个月，总的来说，速度可以。编辑人很好，审稿人虽然问题难，但是尽力补充更多的证据，即使实验补不了（没钱，没精力），也放我一马了。感恩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3de35584971, createdName=ms2000002145400630, createdTime=Mon Sep 06 15:41:33 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098518, encodeId=df432098518a3, content=7月19号投稿，当天就送审了，但是到现在已经三个半月了，依然是Reviews completed: 1，发了催稿信也完全没有回复，想知道大家的提交的文章审稿周期都这么久吗？感觉再这样拖下去很难毕业啊，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d31d5419802, createdName=ms3000000019619113, createdTime=Fri Nov 04 16:54:19 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2022-11-04 ms3000000019619113

7月19号投稿，当天就送审了，但是到现在已经三个半月了，依然是Reviews completed: 1，发了催稿信也完全没有回复，想知道大家的提交的文章审稿周期都这么久吗？感觉再这样拖下去很难毕业啊，担心

48 12

展开12条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务